660 related articles for article (PubMed ID: 26137785)
1. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785
[TBL] [Abstract][Full Text] [Related]
2. Anti-influenza drugs and neuraminidase inhibitors.
Roberts NA
Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
[TBL] [Abstract][Full Text] [Related]
3. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
Bai Y; Jones JC; Wong SS; Zanin M
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917376
[TBL] [Abstract][Full Text] [Related]
4. Strategies of development of antiviral agents directed against influenza virus replication.
Hsieh HP; Hsu JT
Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
[TBL] [Abstract][Full Text] [Related]
5. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
6. [M2 inhibitors and neuraminidase inhibitors].
Klebe G; Schlitzer M
Pharm Unserer Zeit; 2011 Mar; 40(2):144-50. PubMed ID: 21630541
[No Abstract] [Full Text] [Related]
7. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
8. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors targeting the influenza virus hemagglutinin.
Li F; Ma C; Wang J
Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
[TBL] [Abstract][Full Text] [Related]
11. New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.
Oxford JS; Novelli P; Sefton A; Lambkin R
Antivir Chem Chemother; 2002 Jul; 13(4):205-17. PubMed ID: 12495208
[TBL] [Abstract][Full Text] [Related]
12. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
13. Antivirals--current trends in fighting influenza.
Król E; Rychłowska M; Szewczyk B
Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
[TBL] [Abstract][Full Text] [Related]
14. Antiviral strategies against influenza virus: towards new therapeutic approaches.
Loregian A; Mercorelli B; Nannetti G; Compagnin C; Palù G
Cell Mol Life Sci; 2014 Oct; 71(19):3659-83. PubMed ID: 24699705
[TBL] [Abstract][Full Text] [Related]
15. A review of neuraminidase inhibitor susceptibility in influenza strains.
Spanakis N; Pitiriga V; Gennimata V; Tsakris A
Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1325-36. PubMed ID: 25301229
[TBL] [Abstract][Full Text] [Related]
16. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
18. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
19. Recent strategies in the search for new anti-influenza therapies.
Wilson JC; von Itzstein M
Curr Drug Targets; 2003 Jul; 4(5):389-408. PubMed ID: 12816348
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
